Researchers use D360 to query research data efficiently across different data sources and to create visualizations for both small molecules and biological agents. The result? Our industry-leading software D360 enables…
Model-informed drug development (MIDD) is a network of closely integrated ecosystems that can seamlessly position a new drug candidate while minimizing uncertainty in technical and regulatory success. Indeed, MIDD affords…
Princeton, NJ, May 17, 2022. Certara, Inc., a global leader in biosimulation, today announced that the Company was Certified™ by Great Place to Work® in its first year of participation. …
Have you ever wondered what it would be like to be a Regulatory or Medical Writer in the pharmaceutical industry? Certara’s global regulatory writing team includes PhDs, MDs, PharmDs, scientists,…
Our drug development project management services streamline complex workflows, ensuring your projects are delivered on time & within scope.
Accelerate success with our expert drug development strategy consulting, project management, clinical oversight & operational support services.
Physiologically-based pharmacokinetic (PBPK) modeling is being increasingly used in drug development to avoid unnecessary clinical drug–drug interaction (DDI) studies and inform drug labels. Thus, regulatory agencies are recommending more rigorous…
© 2025 Certara. All Rights Reserved. | Privacy policy
